Glucose sensor reveals your personal 'Blood sugar danger Zone' – and a simple fix

NCT ID NCT07618663

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study investigates whether continuous glucose monitor (CGM) data can pinpoint the time of day when a person with prediabetes experiences the largest blood sugar spikes after eating. Participants wear a CGM and activity tracker for 10 days to identify their personal 'vulnerability window.' They are then randomly assigned to either shift their largest meal away from that window and take a short walk after it, or to receive general health advice. The goal is to see if this personalized timing reduces post-meal glucose exposure over 4 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Phenotype-guided meal timing and postprandial walking

What this could lead to

If successful, this approach could offer a simple, personalized lifestyle strategy to help people with prediabetes better manage their blood sugar without medication.

What could go wrong

This is a small, early-stage trial with only 105 participants and a short 4-week follow-up. Results may not apply to everyone, and adherence to the personalized schedule could be challenging.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES (INSULIN RESISTANCE, IMPAIRED GLUCOSE TOLERANCE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus glucose intolerance Insulin Resistance prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shifa International hospital

    RECRUITING

    Lahore, Shaikhupura, 50, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••